DOI: 10.1055/s-00000071

Seminars in Neurology

References

Kappos L, Li D, Calabresi PA , et al.
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.

Lancet 2011;
378 (9805) 1779-1787

Download Bibliographical Data

Search in:
Access: